Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Nov 28, 2008; 14(44): 6858-6862
Published online Nov 28, 2008. doi: 10.3748/wjg.14.6858
Published online Nov 28, 2008. doi: 10.3748/wjg.14.6858
Table 3 Changes in body weight and serum proteins before and after treatment with rhGH
The days when treated with rhGH | |||
0 | 4 | 7 | |
Body weight (kg) | 37.39 ± 12.48 | 38.64 ± 12.84 | 39.13 ± 12.19 |
Body mass index (kg/m2) | 14.37 ± 3.28 | 15.21 ± 3.41 | 15.40 ± 3.24 |
Total proteins (g/L) | 63.51 ± 2.47 | 70.52 ± 5.13b | 74.89 ± 5.16b |
Albumin (g/L) | 35.74 ± 1.75 | 39.44 ± 1.18b | 42.39 ± 1.68b |
Prealbumin (mg/L) | 180.88 ± 48.28 | 231.38 ± 52.31 | 286.38 ± 65.61a |
Transferrin (g/L) | 2.41 ± 0.14 | 2.49 ± 0.12 | 2.61 ± 0.12a |
Fibronectin (mg/L) | 172.5 ± 21.4 | 236.3 ± 16.5b | 275.8 ± 16.9b |
- Citation: Gu GS, Ren JA, Li N, Li JS. Effects of recombinant human growth hormone on enterocutaneous fistula patients. World J Gastroenterol 2008; 14(44): 6858-6862
- URL: https://www.wjgnet.com/1007-9327/full/v14/i44/6858.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.6858